Robert Koch-Institut

The Robert Koch Institute (RKI) is Germany's national public health institute. It plays a crucial role in disease control and prevention, conducting research, surveillance, and providing recommendations to policymakers. The RKI is currently newsworthy due to two separate health concerns. Firstly, there are developments regarding Long Covid treatment. While the articles don't explicitly mention the RKI's direct involvement in the decision, the institute's research and data likely inform policy decisions related to healthcare coverage for Long Covid patients. Specifically, statutory health insurance funds will soon cover certain prescription medications for Long Covid. Secondly, the RKI is involved in monitoring the emergence of the Mpox clade Ib variant in Germany. This variant, which has caused significant illness and fatalities in Africa, is a zoonotic virus, highlighting the RKI's role in tracking and responding to emerging infectious diseases and potential public health threats.